Refine Your Search

  • Solutions

  • Therapeutic Areas

  • Resource Type

Certara and Veristat Expand Clinical Trial Service Offerings with New Partnership

Collaboration offers clients more streamlined and efficient approach to clinical trial planning ST. LOUIS, MO and HOLLISTON, MA – May 14, 2013 – Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through clinical development, and Veristat, LLC., a leading full service clinical research organization, today […]

More Info

Time to Tumor Growth Helps Predict Survival Benefit of Bevacizumab for Patients

Paper published in the Journal of Clinical Oncology proposes new mathematical modeling approach to analyzing oncology clinical trial data ST. LOUIS, MO – May 8, 2013 – Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, announced that its Pharsight Consulting Services has […]

Therapeutic Area: Oncology/Hematology
More Info

Certara Launches Drug Development Consulting Services for Asia

Hidefumi Kasai Joins Certara’s Pharsight Scientific Consulting Services Team ST. LOUIS, MO – April 1, 2013 – Certara™ (headquartered in St. Louis, MO; Location of Japan office: Minato-ku, Tokyo), leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through clinical development, today welcomed Hidefumi Kasai to lead the Pacific […]

More Info

Certara Signs Partnership Agreement with ChemAxon

Certara’s D360 to offer access to ChemAxon’s MarvinSketch and JChem Cartridge for Oracle. ST. LOUIS, MO – March 19, 2013 – Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through clinical development, announced that Certara and ChemAxon have signed a partnership agreement. The partnership will focus on […]

More Info

Certara Releases Version 7.0 of D360

Certara’s latest version of D360 adds important user desired features to support enhanced scientific data access and analysis. ST. LOUIS, MO – February 27, 2013 – Certara™, a leading provider of scientific software and consulting services to improve productivity and decision-making from drug discovery through clinical development, is pleased to announce the next major release […]

Solution: Scientific Informatics
More Info

Certara Supports Eleven Recent Drug Approvals through Model-based Drug Development

Pharsight Consulting Services applies quantitative models to decision making ST. LOUIS, MO – February 13, 2013 – Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through clinical development, published a new white paper that summarizes its involvement and support of eleven drug approvals over the past […]

More Info

Certara Establishes KSU College of Veterinary Medicine as Latest Phoenix Center of Excellence

Collaboration to strengthen PK/PD modeling approaches used in animal health ST. LOUIS, MO – February 5, 2013 – Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through clinical development, announced that the Institute of Computational Comparative Medicine (ICCM) at Kansas State University has been named a Phoenix® Center […]

Solution: PK/PD Modeling & Simulation
More Info

Certara Signs Partnership Agreement with Thomson Reuters

Certara’s D360 to offer access to Thomson Reuters’s Cortellis to integrate internal with external data ST. LOUIS, MO – January 15, 2013 – Certara, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through clinical development, announced that Certara and Thomson Reuters have signed a partnership agreement. The […]

More Info

Plexxikon Selects Certara’s D360 for Scientific Data Access and Analysis

D360 allows Plexxikon’s researchers to easily query and analyze biological assay and chemical registration data from a single dashboard. ST. LOUIS, MO – December 5, 2012 – Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, announced that Plexxikon selected Certara’s D360™ software solution for scientific data […]

Solution: Scientific Informatics
More Info

Certara Expands Senior Scientific Team

Christine Garnett joins as Principal Scientist to lead cardiac safety software tool development and cardiac safety assessment consulting practice ST. LOUIS, MO – September 6, 2012 – Certara™, a leading provider of scientific software and consulting services to improve productivity and decision-making from drug discovery through drug development, today announced that Christine E. Garnett, PharmD  will join […]

More Info
Learn More LinkedIn Twitter Facebook Email